RAC 1.27% $1.55 race oncology ltd

RAC - Charts & Price Action, page-18525

  1. 272 Posts.
    lightbulb Created with Sketch. 1047
    There is still a few basic things the broader RACE team can do to help themselves and improve sentiment among existing shareholders and potentially attract the interest of other shareholders, namely:

    - Pete Smith following through with his comments from the AGM regarding his intent to buy RAC shares on-market. If he believes the Triangle Report is credible, what is he waiting for? How cheap does it need to get before he moves?
    - Would Pete consider buying a chunk off JC (if he wants to sell more) or alternatively find a soph/insto wanting to take a stake in the company.
    - RAC Directors (other than Dr T) exercising options early. The $$ they require to do this is insignificant, so the DCB excuse of 'I can't afford it' should not apply here.

    It is going to be a long 5+ months for some investors while the important box ticking goes on behind the scenes to get RC220 approved and clinical trials up and running for H2 - so simple, tangible actions such as the above are important first steps to rebuild shareholder trust after a turbulent 2023.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.020(1.27%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.